Schwartz Elissa J. 4
4 · GALECTIN THERAPEUTICS INC · Filed Feb 7, 2024
Insider Transaction Report
Form 4
Schwartz Elissa J.
Director
Transactions
- Award
Stock Option (right to buy)
2024-01-24+50,000→ 50,000 totalExercise: $1.72Exp: 2034-01-24→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The stock options were issued pursuant to the Galectin Therapeutics, Inc. 2019 Omnibus Equity Incentive Plan.
- [F2]The options vest 100% on December 31, 2024.